Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Public ClinicalTrials.gov record NCT00083174. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RATIONALE: The MAP.3 study was designed to test whether hormone therapy using exemestane may prevent breast cancer by blocking the production of estrogen. PURPOSE: The study protocol was amended in May 2011 and the current purpose of the study is to allow all study participants the opportunity to complete 5 years of exemestane.
Study identification
- NCT ID
- NCT00083174
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 4,560 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 35 Years and older
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2, 2004
- Primary completion
- Mar 24, 2011
- Completion
- Jan 21, 2018
- Last update posted
- Aug 24, 2023
2004 – 2018
United States locations
- U.S. sites
- 41
- U.S. states
- 26
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Jefferson Clinic, P.C. | Birmingham | Alabama | 35233 | — |
| UAB Comprehensive Cancer Center-LNB 301 | Birmingham | Alabama | 35294-0111 | — |
| Providence Alaska Medical Center | Anchorage | Alaska | 99508 | — |
| University of California, San Diego | La Jolla | California | 92037 | — |
| University of California at Davis | Sacramento | California | 95817 | — |
| Los Angeles Biomedical Research Institute | Torrance | California | 90502 | — |
| University of Connecticut Health Center | Farmington | Connecticut | 06032 | — |
| Whittingham Cancer Center at Norwalk Hospital | Norwalk | Connecticut | 06856 | — |
| The George Washington University | Washington D.C. | District of Columbia | 20037 | — |
| Mayo Clinic Jacksonville | Jacksonville | Florida | 32224 | — |
| University of Miami School of Medicine | Miami | Florida | 33136 | — |
| Georgia Cancer Specialists | Tucker | Georgia | 30084 | — |
| John H. Stroger, Jr Hospital of Cook County | Chicago | Illinois | 60612 | — |
| Mercy Hospital and Medical Center | Chicago | Illinois | 60616 | — |
| The University of Chicago Medical Center | Chicago | Illinois | 60637-1470 | — |
| Loyola University Medical Centre | Maywood | Illinois | 60153 | — |
| Trinity Medical Center | Moline | Illinois | 61265 | — |
| Mid-Illinois Hematology and Oncology Associates, Ltd. | Normal | Illinois | 61761 | — |
| Carle Cancer Centre | Urbana | Illinois | 61801 | — |
| Indiana University Medical Center | Indianapolis | Indiana | 46202 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160-7820 | — |
| Maine Center for Cancer Medicine and Blood Disorders | Scarborough | Maine | 04074-9308 | — |
| Suburban Hospital Cancer Program | Bethesda | Maryland | 20817 | — |
| MedStar Health Research Institute | Hyattsville | Maryland | 20782 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| Hutzel Women's Health Specialists | Detroit | Michigan | 48201 | — |
| William Beaumont Hospital | Royal Oak | Michigan | 48073 | — |
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| University of Medicine and Dentistry of New Jersey | Newark | New Jersey | 07107 | — |
| Montefiore Medical Center | The Bronx | New York | 10461 | — |
| Kinston Medical Specialists | Kinston | North Carolina | 28501 | — |
| University of Cincinnati, Barrett Cancer Centre | Cincinnati | Ohio | 45219 | — |
| University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
| Abramson Cancer Center of the | Philadelphia | Pennsylvania | 19104-4283 | — |
| The Memorial Hospital of Rhode Island | Pawtucket | Rhode Island | 02860 | — |
| Fletcher Allen Health Care | Burlington | Vermont | 05401 | — |
| Fred Hutchinson Cancer Research Center | Seattle | Washington | 98109-1024 | — |
| Univ. of Wisconsin Center for Women's Health and | Madison | Wisconsin | 53715 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00083174, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 24, 2023 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00083174 live on ClinicalTrials.gov.